AwardTape · Defense awards · Research and development · Health R&D · HT942524P0072
HT942524P0072: $250K purchase order to Tda Research, Inc
Tda Research, Inc holds a purchase order from Defense Health Agency with $250K obligated since Oct 2023, against a ceiling of $250K. Latest action Sep 23, 2024.
Dha sbir phase i psoralen-uv-a inactivation based high-throughput pathogen inactivation device
| PIID | HT942524P0072 |
|---|---|
| Type | purchase order |
| Company | Tda Research, Inc |
| Agency | Defense Health Agency |
| Contracting office | ARMY MED RES ACQ ACTIVITY |
| Category | Research and development · Health R&D |
| PSC | AN11 HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH |
| NAICS | 541715 RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) |
| Obligated since Oct 2023 | $250K |
| Total obligated (lifetime) | $250K |
| Ceiling (base and all options) | $250K |
| Base date | Jun 11, 2024 |
| Latest action | Sep 23, 2024 |
| End date | Jan 20, 2025 |
| Actions since Oct 2023 | 2 |
| Pricing | Firm fixed price |
| Competition | Competed after exclusion of sources |
| Place of performance | CO |
| Source | USAspending.gov record |
| Reporting lag | DoD 90 days |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Place of performance shows the state only.
Terminal: alerts on new orders and modifications to this contract, and CSV export.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial